The EUCORNEA Congress 2026 will feature a focused IME Symposium exploring one of the most critical challenges in ophthalmology today—inflammation in ocular surface disease (OSD).
Taking place at the Alfândega do Porto Congress Centre, this 75-minute session brings together leading experts to examine how inflammation shapes diagnosis, treatment, and long-term patient outcomes in clinical practice.
Symposium Details
Title: Inflammation in Ocular Surface Disease: Diagnosis and Management in Today’s Practice
Date: Saturday, May 23, 2026
Time: 13:15 – 14:30 WEST
Location: Infante Lecture Hall, Alfândega do Porto Congress Centre
Co-Chairs:
- Béatrice Cochener
- Mario Nubile
Faculty:
- Nacim Bouheraoua
- Vito Romano
- Dalia Said
- Antonio Di Zazzo
Agenda Highlights
- Welcome and Introduction – Mario Nubile
- Understanding Inflammation in Ocular Surface Dysfunction – Nacim Bouheraoua
- Advances in Diagnosis: From Eyelid Margin to Corneal Nerves – Vito Romano
- Targeted Management Strategies in OSD – Dalia Said
- Alteration of the Ocular Surface and Impact of Chronic Demodex Blepharitis – Béatrice Cochener
- Case-Based Panel Discussion: Optimizing Outcomes in Clinical Practice – Antonio Di Zazzo
- Final Summary and Conclusion – Mario Nubile
What to Expect
This symposium brings together leading experts for a structured exploration of inflammation across the ocular surface continuum, spanning core concepts, advanced diagnostics, and targeted management strategies. The program culminates in a dynamic panel discussion focused on optimizing real-world clinical outcomes, with interactive audience response segments integrated throughout to actively engage participants and assess educational impact.
Industry Support
This IME Symposium is supported by Tarsus Pharmaceuticals and Alcon.
Join us in Porto for an engaging session that connects clinical insight with practical application in ocular surface disease management.
